Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke throughout the world. Patients with severe arterial stenosis and a recent stroke or transient ischemic attack are at high risk of recurring stroke. In an attempt to improve the clinical outcome of patients with severe, symptomatic ICAD, percutaneous transluminal angioplasty and intracranial stenting have become treatment options over the last years. Follow-up imaging of patients with ICAD that underwent intracranial stenting is generally done using 2D digitally subtracted angiography. Since often the vessel path is curved and the neointimal hyperplasia (NH) is eccentric, in-stent restenosis (ISR) may be under- or overestimated using 2D techniques.
- Bioengineering Division
Quantitative In Vivo Evaluation of Neointimal Hyperplasia Using High-Resolution Contrast-Enhanced Cone-Beam Computed Tomography
- Views Icon Views
- Share Icon Share
- Search Site
van der Bom, IMJ, Strittmatter, L, Hendricks, GH, Kühn, AL, Wakhloo, AK, & Gounis, MJ. "Quantitative In Vivo Evaluation of Neointimal Hyperplasia Using High-Resolution Contrast-Enhanced Cone-Beam Computed Tomography." Proceedings of the ASME 2013 Summer Bioengineering Conference. Volume 1A: Abdominal Aortic Aneurysms; Active and Reactive Soft Matter; Atherosclerosis; BioFluid Mechanics; Education; Biotransport Phenomena; Bone, Joint and Spine Mechanics; Brain Injury; Cardiac Mechanics; Cardiovascular Devices, Fluids and Imaging; Cartilage and Disc Mechanics; Cell and Tissue Engineering; Cerebral Aneurysms; Computational Biofluid Dynamics; Device Design, Human Dynamics, and Rehabilitation; Drug Delivery and Disease Treatment; Engineered Cellular Environments. Sunriver, Oregon, USA. June 26–29, 2013. V01AT13A027. ASME. https://doi.org/10.1115/SBC2013-14739
Download citation file: